AnaptysBio Inc buy Guggenheim
Start price
10.03.25
/
50%
€15.30
Target price
10.03.26
-
Performance (%)
161.44%
Price
23.01.26
€40.00
Summary
This prediction is currently active. With a performance of 161.44% the BUY prediction by Guggenheim is a big success. This prediction currently runs until 10.03.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| AnaptysBio Inc | 2.564% | 2.564% |
| iShares Core DAX® | -1.764% | 2.259% |
| iShares Nasdaq 100 | -1.632% | -0.193% |
| iShares Nikkei 225® | -2.451% | 4.086% |
| iShares S&P 500 | -2.252% | -0.151% |
Comments by Guggenheim for this prediction
In the thread AnaptysBio Inc diskutieren
AnaptysBio, Inc. (NASDAQ: ANAB) had its "buy" rating re-affirmed by analysts at Guggenheim.
Ratings data for ANAB provided by MarketBeat